| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/02/2009 | WO2009079683A1 Translocator protein ligands |
| 07/02/2009 | WO2009064444A9 Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents |
| 07/02/2009 | WO2009049305A3 5- (2-hydroxyphenyl) tetrazoles as hsp90 inhibitors against cancer |
| 07/02/2009 | WO2009046832A3 Short peptides used in medicine |
| 07/02/2009 | WO2009042809A8 Stable imatinib compositions |
| 07/02/2009 | WO2009037001A4 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 07/02/2009 | WO2009035351A3 Galenic form of drug for treating internal cancerous infections and method for making same |
| 07/02/2009 | WO2009033762A3 Use of endothelin-3 as a therapeutic agent |
| 07/02/2009 | WO2009033739A3 Use of a peptide as a therapeutic agent |
| 07/02/2009 | WO2009033678A3 Use of a tuftsin as a therapeutic agent |
| 07/02/2009 | WO2009027641A3 Materials and methods for exploiting synthetic lethality in mismatch repair-deficient cancers |
| 07/02/2009 | WO2009017838A3 Combinations of jak-2 inhibitors and other agents |
| 07/02/2009 | WO2009016410A3 Chemical compounds 831 |
| 07/02/2009 | WO2009013545A3 Chemical compounds |
| 07/02/2009 | WO2009010925A3 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 07/02/2009 | WO2008142198A3 A method for inhibiting or stimulating angiogenesis in an individual |
| 07/02/2009 | WO2008106606A3 Carotenoid analogs and derivatives in the treatment of prostate cancer |
| 07/02/2009 | WO2008058380A8 Cancerous disease modifying antibodies |
| 07/02/2009 | WO2007134876A8 HIGH AFFINITY HUMAN AND HUMANIZED ANTI-α5β1 INTEGRIN FUNCTION BLOCKING ANTIBODIES WITH REDUCED IMMUNOGENICITY |
| 07/02/2009 | WO2007109045A8 Heterocyclic organic compounds for the treatment of in particular melanoma |
| 07/02/2009 | US20090171103 Triptolide Derivatives for Modulation of Apoptosis and Immunosuppression |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170928 Synthesis of oligo/poly(catechins) and methods of use |
| 07/02/2009 | US20090170927 Functionalized phenolic compounds and polymers therefrom |
| 07/02/2009 | US20090170925 Methods for prognosing the ability of a zearalenone analog compound to treat cancer |
| 07/02/2009 | US20090170922 Benzimidazole derivatives and their use as a medicament |
| 07/02/2009 | US20090170920 Substituted hydantoins |
| 07/02/2009 | US20090170911 Novel azole compound |
| 07/02/2009 | US20090170904 Substituted benzimidazoles and methods of their use |
| 07/02/2009 | US20090170896 c-Met modulators and methods of use |
| 07/02/2009 | US20090170886 4-[(3-hydroxybenzyl)oxy]-2-(trifluoromethyl)benzonitrile; selective androgen receptor modulators; decrease excess sebum secretions; stimulants of hair growth at higher rates of cosmetically acceptable hair growth in patients with alopecia; acne; skin disorders; prostate cancer |
| 07/02/2009 | US20090170882 Methods and compositions |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170880 Methods and Means for the Treatment of Cancer |
| 07/02/2009 | US20090170862 Use of c-kit inhibitors for the treatment of myeloma |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170849 Quinazolinone derivatives having b-raf inhibitory activity |
| 07/02/2009 | US20090170848 Thiazolones for use as pi3 kinase inhibitors |
| 07/02/2009 | US20090170843 podophyllotoxin derivatives such as (2-{3-[4-(3-aminopropylamino)-butylamino]-propylamino}-N-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5,6,8,8a,9-hexahydrofuro[3',4':6,7]naptho[2,3-d][1,3]dioxol-5-yl]-acetamide, used as anticarcinogenic agents |
| 07/02/2009 | US20090170842 Brca1-based breast or ovarian cancer prevention agents and methods of use |
| 07/02/2009 | US20090170838 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170835 Isoindoline derivatives |
| 07/02/2009 | US20090170822 2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs |
| 07/02/2009 | US20090170821 2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170820 2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170819 (20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs |
| 07/02/2009 | US20090170818 Arresting the proliferation of undifferentiated cells and inducing their differentiation; anticancer agents; treating psoriasis, wrinkles, slack skin, dry skin, insufficient sebum secretion, autoimmune disorders, inflammatory diseases, renal osteodystrophy. and obesity; little, if any, calcemic activity |
| 07/02/2009 | US20090170796 Histone Demethylation Mediated By The Nuclear Amine Oxidase Homolog LSD1 |
| 07/02/2009 | US20090170795 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 07/02/2009 | US20090170783 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors |
| 07/02/2009 | US20090170770 Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap 1) inhibitor |
| 07/02/2009 | US20090170769 Cell surface receptor isoforms and methods of identifying and using the same |
| 07/02/2009 | US20090170760 Anti-Cancer Agent Comprising Protein C Inhibitor |
| 07/02/2009 | US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 07/02/2009 | US20090170172 Recombinant Methods and Materials for Producing Epothilone and Epothilone Derivatives |
| 07/02/2009 | US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 07/02/2009 | US20090169660 A composition of radix codonopsis and radix astragali, a method for preparation thereof and its application |
| 07/02/2009 | US20090169658 Toona sinensis extract for suppressing proliferation and inducing apoptosis of osteosarcoma cells |
| 07/02/2009 | US20090169638 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof |
| 07/02/2009 | US20090169613 Targeting of tumor stem cells through selective silencing of boris expression |
| 07/02/2009 | US20090169611 Gel-Formulations of Hydrophobic Photosensitizers for Mucosal Applications |
| 07/02/2009 | US20090169591 Medical articles for the treatment of tumors |
| 07/02/2009 | US20090169586 Stable packaged dosage form and process therefor |
| 07/02/2009 | US20090169580 Attenuated vaccines for non-segmented negative sense rna viruses |
| 07/02/2009 | US20090169574 Heteroclitic analogs and related methods |
| 07/02/2009 | US20090169570 Methods and agents for improving targeting of cd138 expressing tumor cells |
| 07/02/2009 | US20090169563 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 07/02/2009 | US20090169556 Vascular endothelial cell growth factor antagonists |
| 07/02/2009 | US20090169555 Administering the kinase to regulate mitogenesis, apoptosis, neuronal development, chemotaxis, angiogenesis or an inflammatory response inclding developmental retardation, excessive apoptosis, cancer, restenosis and diabetic neuropathy; screening for drugs that stimulate or inhibit lipid phosphorylation |
| 07/02/2009 | US20090169547 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | US20090169541 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor |
| 07/02/2009 | US20090169537 Glutadon |
| 07/02/2009 | US20090169522 Mesenchymal stem cells expressing tnf-a receptor |
| 07/02/2009 | US20090169485 Gene therapy and pharmaceutical composition for prevention and treatment of lung cancer |
| 07/02/2009 | US20090169478 In Vivo Imaging and Therapy with Magnetic Nanoparticle Conjugates |
| 07/02/2009 | US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 07/02/2009 | DE102007063056A1 New anthraquinone derivatives are protein kinase inhibitors useful e.g. to treat autoimmune-, inflammatory-, metabolic-, organ-, cardiovascular-, neurological and neurodegenerative-, hormone dependent-disease, asthma, depression and stroke |
| 07/02/2009 | CA2710646A1 Medicament for the treatment of cancer of the pancreas |
| 07/02/2009 | CA2710483A1 Methods and agents for improving targeting of cd138 expressing tumor cells |
| 07/02/2009 | CA2710471A1 Immunoconjugates targeting cd138 and uses thereof |
| 07/02/2009 | CA2710453A1 Agents targeting cd138 and uses thereof |
| 07/02/2009 | CA2710347A1 Pm-2 antibodies and methods for treating metastasis |
| 07/02/2009 | CA2710122A1 Thiazole derivatives used as pi 3 kinase inhibitors |
| 07/02/2009 | CA2710039A1 Compounds and method for treatment of cancer |
| 07/02/2009 | CA2710016A1 Translocator protein ligands |
| 07/02/2009 | CA2709937A1 Halogenated analogues of anti-fibrotic agents |
| 07/02/2009 | CA2709915A1 New polypeptides having affinity for her2 |
| 07/02/2009 | CA2709635A1 Polypeptide-nucleic acid conjugates and uses thereof |
| 07/02/2009 | CA2709536A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer |
| 07/02/2009 | CA2709514A1 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
| 07/02/2009 | CA2709169A1 Pyridazine derivatives useful as fungicides and for the treatment of cancer |
| 07/02/2009 | CA2708686A1 Methods of inhibiting tumor growth using ttk antagonists |
| 07/02/2009 | CA2708449A1 Method for improving the therapeutic efficacy of the curcuminoids and their analogues |
| 07/02/2009 | CA2708407A1 Humanized anti-human cd34 antibody, the preparation method and uses thereof |
| 07/02/2009 | CA2708312A1 Spiroindolinone derivatives as anticancer agents |
| 07/02/2009 | CA2708176A1 Azaindolizines and methods of use |
| 07/02/2009 | CA2707650A1 Substituted hydantoins as mek kinase inhibitors |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |